Regenxbio Inc (RGNX)

NASDAQ
19.65
+0.08(+0.41%)
After Hours
19.65
0.00(0.00%)
- Real-time Data
  • Volume:
    440,142
  • Day's Range:
    18.69 - 19.90
  • 52 wk Range:
    18.69 - 46.46

RGNX Overview

Prev. Close
19.57
Day's Range
18.69-19.9
Revenue
473.68M
Open
19.56
52 wk Range
18.69-46.46
EPS
1.53
Volume
440,142
Market Cap
844.13M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
407,458
P/E Ratio
12.81
Beta
1.23
1-Year Change
-44.78%
Shares Outstanding
43,133,927
Next Earnings Date
Aug 10, 2022
What is your sentiment on Regenxbio Inc?
or
Market is currently closed. Voting is open during market hours.

Regenxbio Inc News

Regenxbio Inc Analysis

Regenxbio Inc Company Profile

Regenxbio Inc Company Profile

Employees
372

REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company’s lead product candidate is RGX-314, which is in Phase III clinical trial for the treatment of wet age-related macular degeneration. It is also developing RGX-121 that is in Phase I/II clinical trial to treat mucopolysaccharidosis type II;RGX-111, which is in Phase I/II clinical trial for treating mucopolysaccharidosis type I;RGX-181 which is in pre clinic stage for the treatment of late-infantile neuronal ceroid lipofuscinosis type II disease;RGX-202, to treat Duchenne muscular dystrophy which is in phase I/II clinical trial; and RGX-381, to treat the ocular manifestations of CLN2 disease which is in preclinical stage. REGENXBIO Inc. also licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies; and has a collaboration and license agreement with Neurimmune AG to develop novel gene therapies. REGENXBIO Inc. was founded in 2008 and is headquartered in Rockville, Maryland.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellStrong SellStrong Sell
Technical IndicatorsStrong SellBuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell
  • https://www.reddit.com/r/MicrocapStocksRun/comments/p1otr4/regenxbio_inc_a_compelling_investment_opportunity/?utm_source=share&utm_medium=web2x&context=3
    0
    • It. It is going up FOREVER! The new PARADIGM. IT IS DIFFERENT THIS TIME!
      1
      • RGNX is fully priced and a short sale
        0
        • RGNX is going to 32.50
          1